(Note: Cedarlake Acquisition Corp., a Hong Kong-based SPAC or blank check company, withdrew its IPO plans in an SEC filing dated Aug. 5, 2022. Cedarlake Acquisition filed its S-1 on June 21, 2021, with plans to offer 20 million units at $10 each to raise $200 million. Each unit consisted of one share of common […]

(Note: Cerberus Telecom Acquisition Corp. II withdrew its IPO plans in an SEC filing dated Aug. 5, 2022. This SPAC – the second blank check company backed by Cerberus Capital – had filed to go public on March 15, 2021, with the intent to offer 50 million units at $10 each to raise $500 million. […]

(Note: Science Strategic Acquisition Corp. Charlie withdrew its IPO plans in an SEC filing dated Aug. 8, 2022; this SPAC withdrew its IPO from registration on the same date that its sister SPAC, Science Strategic Acquisition Corp. Bravo, also withdrew its IPO. Both SPACs had filed to go public on March 26, 2021, during the […]

(Note: Science Strategic Acquisition Corp. Bravo withdrew its IPO plans in an SEC filing dated Aug. 8, 2022; the company had filed to go public with its S-1 dated March 26, 2021. This SPAC is one of three special-purpose acquisition companies, also known as blank check companies, backed by the co-founders of Science Inc., a […]

We intend to focus our search for a target business in the biotechnology industry, and we will not consider or undertake a business combination with an entity or business that is based in, or has its principal business operations in, the People’s Republic of China, including Hong Kong and Macau. (Incorporated in Delaware) (Note: BCGF […]

Sacks Parente Golf, Inc. is a technology-forward golf company, with a growing portfolio of golf products, including putting instruments, golf shafts, golf grips and other golf-related products. In April 2022, in consideration of our growth opportunities in shaft technologies, we expanded our manufacturing business to include advanced premium golf shafts by opening a new shaft […]

We are a holding company incorporated as an exempted company on May 28, 2020, under the laws of the Cayman Islands. As a holding company with no material operations of our own, we conduct substantially all of our operations through our PRC (People’s Republic of China) subsidiary and VIEs in China. We are primarily engaged in […]

We are a life sciences company focused on the development of liquid biopsy tests based on the mitochondrial genome. A liquid biopsy offers the opportunity to diagnose disease earlier without the risks of a traditional biopsy, which include infection. Our product candidates are: *Mitomic Prostate Test (MPT™) is currently in development and is being designed as […]

(Note: This is NOT an IPO. This is a NASDAQ uplisting from the OTCQB market. This is a public offering of up to 2.03 million (2,029,703) Class A Units, with each Class A Unit consisting of one share of common stock and one Series X Warrant to buy one share of common stock at an […]

(Note: Blue Water Acquisition Corp. II, the second healthcare-focused blank check company created by the founder of Blue Water Vaccines, withdrew its IPO plans in an SEC filing dated Aug. 3, 2022. Blue Water Acquisition Corp. II filed its S-1, dated Oct. 18, 2021; its confidential filing was submitted to the SEC on Aug. 6, 2021.) […]